A novel nomogram and prognostic factor for metastatic renal cell carcinoma survival in the era of immune checkpoint inhibitors (ICIs)

A novel nomogram and prognostic factor for metastatic renal cell carcinoma survival in the era of immune checkpoint inhibitors (ICIs)

Patients with metastatic renal cell cancer (mRCC) for whom surgery is ineffective may experience a poor prognosis. The different sites where cancer has spread, and the different ways to treat it in the immune checkpoint inhibitors era could help clinical decision-making. In this study, individuals w...

Full description

Bibliographic Details
Main Authors: Mohammed Alradhi, Zewen Zhang, Mohammed Safi, Abdullah Al-danakh, Mokhtar Aldhbi, Salim Baldi, Li kui, Abdulaziz Alradhi, Saeed Bin Hamri, Ka Lun lo, Yi Zhao, Yang Jin
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Pharmacology
Subjects:
metastatic renal cell carcinoma
immune checkpoint inhibitors (ICI)
nomogram
survival
SEER
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.996404/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.996404/full

Similar Items